Cairo – Mubasher: Kahira Pharmaceuticals on Sunday reported a profit of EGP 33 million ($3.72 million) in the first nine months of its fiscal year ended 31 March 2016, up 6.5% year-on-year from EGP 30.97 million ($3.49 million), according to a bourse filing.
Net profits before taxes in March 2016 reached EGP 4.2 million, up from EGP 4.5 million in the same period in 2015.
